Literature DB >> 3488713

Immunogenetic heterogeneity of rheumatoid arthritis.

M L Westedt, F C Breedveld, G M Schreuder, J D'Amaro, A Cats, R R de Vries.   

Abstract

Association of HLA-DR4/Dw4 with rheumatoid arthritis (RA) is well established, but conflicting data exist on a possible association with the severity of the disease, including its extra-articular manifestations. In order to investigate whether a subgroup of RA is preferentially associated with DR4, HLA typing was performed in two groups of patients with severe extra-articular manifestations (Felty's syndrome and histologically proved leucocytoclastic vasculitis), patients with severe joint destruction (seropositive and seronegative), a group with only mild joint destruction, and in healthy controls. The frequency of HLA-DR4 was significantly raised in all patient groups compared with that in healthy controls. The two groups with severe extra-articular manifestations, however, both had a DR4 frequency of 92%, which was significantly (p = 0.002) higher than the 62.7% found in the remaining patients. No significant differences were observed between severe or mild joint destruction and seropositivity or seronegativity in the groups without the above-mentioned extra-articular manifestations. From these data we concluded that DR4 is preferentially associated with severe extra-articular disease manifestations of RA. This observation provides an immunogenetic basis for the disease heterogeneity and for the immunological analogy between RA and leprosy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488713      PMCID: PMC1001933          DOI: 10.1136/ard.45.7.534

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  26 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Increased frequency of HLA-Cw3 and HLA-Dw4 in rheumatoid arthritis.

Authors:  A J McMichael; T Sasazuki; H O McDevitt; R O Payne
Journal:  Arthritis Rheum       Date:  1977-06

Review 3.  HL-A antigens and disease. Statistical and genetical considerations.

Authors:  A Svejgaard; C Jersild; L S Nielsen; W F Bodmer
Journal:  Tissue Antigens       Date:  1974

4.  HLA-D and DR determinants in rheumatoid arthritis.

Authors:  D Jaraquemada; C Pachoula-Papasteriadis; H Festenstein; J A Sachs; I M Roitt; M Corbett; B Ansell
Journal:  Transplant Proc       Date:  1979-06       Impact factor: 1.066

5.  HLA-DRw4 and rheumatoid arthritis.

Authors:  G S Panayi; P H Wooley; J R Batchelor
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

6.  A modified latex-fixation test for the detection of rheumatoid factors.

Authors:  F Klein; W Bronsveld; W Norde; L K Van Romunde; J M Singer
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

7.  Ankylosing spondylitis in African Blacks.

Authors:  I M Chalmers
Journal:  Arthritis Rheum       Date:  1980-12

8.  HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production.

Authors:  J H Dobloug; O Førre; E Kåss; E Thorsby
Journal:  Arthritis Rheum       Date:  1980-03

9.  Rheumatoid arthritis and B lymphocyte alloantigen HLA-DRw4.

Authors:  O Scherak; J S Smolen; W R Mayr
Journal:  J Rheumatol       Date:  1980 Jan-Feb       Impact factor: 4.666

10.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

Authors:  P Stastny
Journal:  N Engl J Med       Date:  1978-04-20       Impact factor: 91.245

View more
  9 in total

Review 1.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

2.  DR4 prevalence related to the age at disease onset in female patients with rheumatoid arthritis.

Authors:  J M Hazes; B A Dijkmans; J M Hoevers; J J Janson; R R de Vries; J P Vandenbroucke; A Cats
Journal:  Ann Rheum Dis       Date:  1989-05       Impact factor: 19.103

3.  Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

Authors:  A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

4.  Perivascular infiltration in normal skin of patients with rheumatoid arthritis: association with rheumatoid factors and HLA-DR antigens.

Authors:  H J Bernelot Moens; H J Ament; T M Vroom; T E Feltkamp; J K van der Korst
Journal:  Ann Rheum Dis       Date:  1988-10       Impact factor: 19.103

5.  DQw7 and the C4B null allele in rheumatoid arthritis and Felty's syndrome.

Authors:  R Clarkson; A S Bate; D M Grennan; C Chattopadhyay; P Sanders; M Davis; C Kelly
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

6.  Homozygosity for the HLA-DRB1 allele selects for extraarticular manifestations in rheumatoid arthritis.

Authors:  C M Weyand; C Xie; J J Goronzy
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Absence of an association between HLA-DRB1*04 and rheumatoid arthritis in newly diagnosed cases from the community.

Authors:  W Thomson; L Pepper; A Payton; D Carthy; D Scott; W Ollier; A Silman; D Symmons
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

8.  The effect of methylprednisolone pulse therapy on methotrexate treatment of rheumatoid arthritis.

Authors:  M J van der Veen; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

9.  Immunopathological abnormalities in the normal skin of patients with rheumatoid arthritis in relation to clinical and serological findings: a one year follow up study.

Authors:  M L Westedt; B J Vermeer; C J Meijer; M R Daha; W M Baldwin; A Cats
Journal:  Ann Rheum Dis       Date:  1987-03       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.